DEBORAH WOLOSKI: Open Payments
NPI 1285767186 · BROWNSVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,710 in 35 payments from 15 companies in 2025. Trend: 2023 $2,025 · 2024 $2,714 · 2025 $1,710
Food & beverage: $1,710
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $256 |
| E.R. Squibb & Sons, L.L.C. | 4 | $253 |
| ABBVIE INC. | 7 | $239 |
| Alkermes, Inc. | 6 | $218 |
| KYOWA KIRIN, INC. | 1 | $125 |
| Inspire Medical Systems, Inc. | 1 | $119 |
| Insulet Corporation | 1 | $104 |
| AstraZeneca Pharmaceuticals LP | 1 | $93 |
| Dexcom, Inc. | 1 | $76 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
Products named: REXULTI, COBENFY, VRAYLAR, LYBALVI, INSPIRE, OMNIPOD, LOKELMA, ARISTADA.
Industry payments across TX — which companies pay providers there.
